The Remicade Biosimilar Global Market Report 2023, provides comprehensive information on the remicade biosimilar market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Remicade Biosimilar Market’s Growth:
https://www.thebusinessresearchcompany.com/report/remicade-biosimilar-global-market-report
The global remicade biosimilar market size is expected to grow from $2.59 billion in 2022 to $3.20 billion in 2023 at a compound annual growth rate (CAGR) of 23.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of remicade biosimilar market is expected to reach $7.4 billion in 2027 at a CAGR of 23.6%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=11952&type=smp
Product innovation is a key trend gaining popularity in the Remicade biosimilar market. Major companies operating in the Remicade biosimilar market are developing innovative products to sustain their position in the market. For instance, in January 2023, Amgen Inc, a US-based biotechnology company, launched Amjevita, a biosimilar version of AbbVie’s Humira, in the US, designed to be as safe and effective as the original drug. Amjevita is the first biosimilar to Humira and is expected to compete with Humira for market share. It is a biological drug used to treat various autoimmune diseases, including rheumatoid arthritis and Crohn’s disease. It is one of the most expensive drugs in the world, generating billions of dollars in sales for AbbVie each year. Amjevita is expected to cost significantly less. In addition to saving money, Amjevita can also offer patients more treatment options.
The remicade biosimilar market is segmented:
1) By Type: 100mg/10ml, 500mg/50ml
2) By Disease Indication: Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriatic Arthritis, Plaque Psoriasis
3) By Application: Blood Disorders, Oncology Diseases
Europe was the largest region in the remicade biosimilar market in 2022.
The table of contents in TBRC’s remicade biosimilar market report includes:
1. Executive Summary
2. Remicade Biosimilar Market Characteristics
3. Remicade Biosimilar Market Trends And Strategies
4. Remicade Biosimilar Market – Macro Economic Scenario
5. Remicade Biosimilar Market Segmentation
.
.
.
26. South America Remicade Biosimilar Market
27. Brazil Remicade Biosimilar Market
28. Middle East Remicade Biosimilar Market
29. Africa Remicade Biosimilar Market
30. Remicade Biosimilar Market Competitive Landscape And Company Profiles
Top Major Players:
- AbbVie Inc
- Novartis AG
- Amgen Inc
- Viatris Inc
- Teva Pharmaceutical Industries Ltd
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
